ST-segment level and slope in exercise-induced myocardial ischemia evaluated with body surface potential mapping

Body surface potential mapping (BSPM) is superior to 12-lead electrocardiography for detection of acute and old myocardial infarctions (MIs). We used BSPM to examine electrocardiographic criteria for acute reversible myocardial ischemia. BSPM with 123 channels was performed in 45 patients with coronary artery disease (CAD) and 25 healthy controls during supine bicycle exercise testing. Of the 45 patients, 18 patients had anterior, 14 had posterior, and 13 had inferior ischemia documented by coronary angiography and thallium scintigraphy. The ST amplitude was measured 60 ms after the J-point and the ST slope calculated by fitting a regression line from the J-point to 60 ms after it. The optimal locations for detecting ST depression and ST-slope decrease were identified. In the pooled CAD patient group, the optimal location for ST depression was 5 cm below standard lead V-5 (CAD group: -70 +/- 70 muV; controls: 70 +/- 80 muV, p<0.001). Using a cut-off value of -10 <mu>V, the ST depression separated the patients with CAD from controls with a sensitivity of 84% and a specificity of 96%. The ST slope became more horizontal in the patient group than in the control group. The optimal location for ST-slope decrease was over the left side (CAD group: 20 +/- 20 muV/s; controls: 720 +/- 320 muV/s, p<0.001). Using a cut-off value of 320 <mu>V/s, the ST slope separated patients with CAD from controls with a sensitivity of 93% at a specificity level of 88%. The area under the receiver operating characteristic curve of ST slope tended to be higher than the one of ST depression (970% vs 93%; p=0.097). In conclusion, regions sensitive for ST depression and for ST-slope decrease could be identified in BSPM, despite variation in the location of ischemia and the presence or absence of a history of Mi. ST slope is a sensitive and specific marker of transient myocardial ischemia, and might perform even better than ST depression. (C) 2001 by Excerpta Medica, Inc.